» Articles » PMID: 34831210

Developmental Pathways Underlying Lung Development and Congenital Lung Disorders

Overview
Journal Cells
Publisher MDPI
Date 2021 Nov 27
PMID 34831210
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Lung organogenesis is a highly coordinated process governed by a network of conserved signaling pathways that ultimately control patterning, growth, and differentiation. This rigorously regulated developmental process culminates with the formation of a fully functional organ. Conversely, failure to correctly regulate this intricate series of events results in severe abnormalities that may compromise postnatal survival or affect/disrupt lung function through early life and adulthood. Conditions like congenital pulmonary airway malformation, bronchopulmonary sequestration, bronchogenic cysts, and congenital diaphragmatic hernia display unique forms of lung abnormalities. The etiology of these disorders is not yet completely understood; however, specific developmental pathways have already been reported as deregulated. In this sense, this review focuses on the molecular mechanisms that contribute to normal/abnormal lung growth and development and their impact on postnatal survival.

Citing Articles

The dynamics of tubulogenesis in development and disease.

Romero A, Walker B, Krneta-Stankic V, Gerner-Mauro K, Youmans L, Miller R Development. 2025; 152(3).

PMID: 39959988 PMC: 11883272. DOI: 10.1242/dev.202820.


Amniotic fluid stem cell extracellular vesicles as a novel fetal therapy for pulmonary hypoplasia: a review on mechanisms and translational potential.

Doktor F, Antounians L, Figueira R, Khalaj K, Duci M, Zani A Stem Cells Transl Med. 2025; 14(1.

PMID: 39823257 PMC: 11740888. DOI: 10.1093/stcltm/szae095.


Lung epithelial-endothelial-mesenchymal signaling network with hepatocyte growth factor as a hub is involved in bronchopulmonary dysplasia.

Sang Y, Qiao L Front Cell Dev Biol. 2024; 12:1462841.

PMID: 39291265 PMC: 11405311. DOI: 10.3389/fcell.2024.1462841.


Wnt5a and Notum Influence the Temporal Dynamics of Cartilaginous Mesenchymal Condensations in Developing Trachea.

Bottasso-Arias N, Mohanakrishnan M, Trovillion S, Burra K, Russell N, Wu Y bioRxiv. 2024; .

PMID: 39282283 PMC: 11398369. DOI: 10.1101/2024.09.02.610014.


An interdisciplinary consensus approach to pulmonary hypertension in developmental lung disease.

Varghese N, Austin E, Galambos C, Mullen M, Yung D, Guillerman R Eur Respir J. 2024; 64(3).

PMID: 39147412 PMC: 11424926. DOI: 10.1183/13993003.00639-2024.


References
1.
Ochieng J, Schilders K, Kool H, Boerema-de Munck A, Buscop-van Kempen M, Gontan C . Sox2 regulates the emergence of lung basal cells by directly activating the transcription of Trp63. Am J Respir Cell Mol Biol. 2014; 51(2):311-22. DOI: 10.1165/rcmb.2013-0419OC. View

2.
Cass D, Crombleholme T, Howell L, Stafford P, Ruchelli E, Adzick N . Cystic lung lesions with systemic arterial blood supply: a hybrid of congenital cystic adenomatoid malformation and bronchopulmonary sequestration. J Pediatr Surg. 1997; 32(7):986-90. DOI: 10.1016/s0022-3468(97)90383-3. View

3.
Metzger R, Klein O, Martin G, Krasnow M . The branching programme of mouse lung development. Nature. 2008; 453(7196):745-50. PMC: 2892995. DOI: 10.1038/nature07005. View

4.
Correia-Pinto J, Gonzaga S, Huang Y, Rottier R . Congenital lung lesions--underlying molecular mechanisms. Semin Pediatr Surg. 2010; 19(3):171-9. DOI: 10.1053/j.sempedsurg.2010.03.003. View

5.
Danopoulos S, Shiosaki J, Al Alam D . FGF Signaling in Lung Development and Disease: Human Versus Mouse. Front Genet. 2019; 10:170. PMC: 6423913. DOI: 10.3389/fgene.2019.00170. View